Search

Jeffrey S. Parkin

Examiner (ID: 2776)

Most Active Art Unit
1648
Art Unit(s)
1648, 1641, 1813, 1671
Total Applications
1731
Issued Applications
935
Pending Applications
260
Abandoned Applications
571

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5661479 [patent_doc_number] => 20060252075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Method for monitoring anti-HIV treatment in HIV infected individuals' [patent_app_type] => utility [patent_app_number] => 11/404115 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20340 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252075.pdf [firstpage_image] =>[orig_patent_app_number] => 11404115 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/404115
Method for monitoring anti-HIV treatment in HIV infected individuals Apr 13, 2006 Abandoned
Array ( [id] => 4553572 [patent_doc_number] => 07838001 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-23 [patent_title] => 'Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses' [patent_app_type] => utility [patent_app_number] => 11/402876 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7952 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/838/07838001.pdf [firstpage_image] =>[orig_patent_app_number] => 11402876 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/402876
Synthetic peptides useful in biological essays for detecting infections caused by group O HIV-1 viruses Apr 12, 2006 Issued
Array ( [id] => 6252354 [patent_doc_number] => 20100028415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus' [patent_app_type] => utility [patent_app_number] => 11/918219 [patent_app_country] => US [patent_app_date] => 2006-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7654 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028415.pdf [firstpage_image] =>[orig_patent_app_number] => 11918219 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/918219
Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus Apr 11, 2006 Abandoned
Array ( [id] => 5661084 [patent_doc_number] => 20060251680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Mannose immunogens for HIV-1' [patent_app_type] => utility [patent_app_number] => 11/376549 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6084 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251680.pdf [firstpage_image] =>[orig_patent_app_number] => 11376549 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376549
Mannose immunogens for HIV-1 Mar 15, 2006 Abandoned
Array ( [id] => 7488821 [patent_doc_number] => 08029797 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-04 [patent_title] => 'Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions' [patent_app_type] => utility [patent_app_number] => 11/817640 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 58 [patent_no_of_words] => 9863 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/029/08029797.pdf [firstpage_image] =>[orig_patent_app_number] => 11817640 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817640
Multivalent HIV immunogenic compositions comprising a pool of lipidated and nonlipidated peptides representing Gag and Env variable regions Feb 27, 2006 Issued
Array ( [id] => 5785448 [patent_doc_number] => 20060205070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'HIV TEV compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/364873 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 27058 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205070.pdf [firstpage_image] =>[orig_patent_app_number] => 11364873 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/364873
HIV TEV compositions and methods of use Feb 26, 2006 Abandoned
Array ( [id] => 5619428 [patent_doc_number] => 20060188961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of modified vaccinia virus ankara' [patent_app_type] => utility [patent_app_number] => 11/355948 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19129 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188961.pdf [firstpage_image] =>[orig_patent_app_number] => 11355948 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/355948
Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara Feb 16, 2006 Issued
Array ( [id] => 5514721 [patent_doc_number] => 20090215028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV' [patent_app_type] => utility [patent_app_number] => 11/884668 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20964 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215028.pdf [firstpage_image] =>[orig_patent_app_number] => 11884668 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884668
Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV Feb 15, 2006 Abandoned
Array ( [id] => 9749597 [patent_doc_number] => 08841068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Human immunodeficiency virus antiviral screening assay involving the detection of CEM15 expression' [patent_app_type] => utility [patent_app_number] => 11/816063 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 28040 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11816063 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/816063
Human immunodeficiency virus antiviral screening assay involving the detection of CEM15 expression Feb 12, 2006 Issued
Array ( [id] => 4785483 [patent_doc_number] => 20080138812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Screening Method For Competitive Hiv Rt Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/814841 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6957 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138812.pdf [firstpage_image] =>[orig_patent_app_number] => 11814841 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/814841
Screening Method For Competitive Hiv Rt Inhibitors Feb 5, 2006 Abandoned
Array ( [id] => 4852037 [patent_doc_number] => 20080317779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Hiv Tat-Cd4 Hybrid Molecules and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/883696 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24606 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317779.pdf [firstpage_image] =>[orig_patent_app_number] => 11883696 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/883696
Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes Feb 2, 2006 Issued
Array ( [id] => 5667595 [patent_doc_number] => 20060172945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Human neutrophil alpha-defensin 4 inhibition of HIV-1' [patent_app_type] => utility [patent_app_number] => 11/347538 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2991 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172945.pdf [firstpage_image] =>[orig_patent_app_number] => 11347538 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/347538
Human neutrophil alpha-defensin 4 inhibition of HIV-1 Feb 2, 2006 Abandoned
Array ( [id] => 5700015 [patent_doc_number] => 20060216699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Peptides for the detection of HIV-1 group O' [patent_app_type] => utility [patent_app_number] => 11/341363 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6975 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216699.pdf [firstpage_image] =>[orig_patent_app_number] => 11341363 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/341363
Peptides for the detection of HIV-1 group O Jan 25, 2006 Abandoned
Array ( [id] => 9073907 [patent_doc_number] => 08551483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Methods of treating viral infections by administering KIR2DL-binding antibodies' [patent_app_type] => utility [patent_app_number] => 11/813399 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15588 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11813399 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813399
Methods of treating viral infections by administering KIR2DL-binding antibodies Jan 5, 2006 Issued
Array ( [id] => 836816 [patent_doc_number] => 07393631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Method for purifying adenoviruses' [patent_app_type] => utility [patent_app_number] => 11/326275 [patent_app_country] => US [patent_app_date] => 2006-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3412 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393631.pdf [firstpage_image] =>[orig_patent_app_number] => 11326275 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/326275
Method for purifying adenoviruses Jan 4, 2006 Issued
Array ( [id] => 4681837 [patent_doc_number] => 20080248063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Hetero-Oligomeric Hiv Envelope Proteins' [patent_app_type] => utility [patent_app_number] => 11/722336 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8284 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248063.pdf [firstpage_image] =>[orig_patent_app_number] => 11722336 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/722336
Hetero-Oligomeric Hiv Envelope Proteins Dec 27, 2005 Abandoned
Array ( [id] => 852883 [patent_doc_number] => 07378265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses' [patent_app_type] => utility [patent_app_number] => 11/301160 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12935 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378265.pdf [firstpage_image] =>[orig_patent_app_number] => 11301160 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/301160
Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses Dec 11, 2005 Issued
Array ( [id] => 5613528 [patent_doc_number] => 20060115456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Replication-competent adenoviral vectors' [patent_app_type] => utility [patent_app_number] => 11/282319 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16599 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115456.pdf [firstpage_image] =>[orig_patent_app_number] => 11282319 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/282319
Replication-competent adenoviral vectors Nov 16, 2005 Issued
Array ( [id] => 4651028 [patent_doc_number] => 20080038284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Human Immunodeficiency Virus Vaccine' [patent_app_type] => utility [patent_app_number] => 11/666732 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8217 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038284.pdf [firstpage_image] =>[orig_patent_app_number] => 11666732 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/666732
Human Immunodeficiency Virus Vaccine Nov 6, 2005 Abandoned
Array ( [id] => 7811136 [patent_doc_number] => 08133666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-13 [patent_title] => 'Method for identifying agents capable of inhibiting APOBEC3C activity in HIV-infected cells' [patent_app_type] => utility [patent_app_number] => 11/577077 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 19578 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/133/08133666.pdf [firstpage_image] =>[orig_patent_app_number] => 11577077 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/577077
Method for identifying agents capable of inhibiting APOBEC3C activity in HIV-infected cells Oct 30, 2005 Issued
Menu